246710.KQ
T&R Biofab Co., Ltd.
KOE · Healthcare · Medical - Specialties · KR
KRW 2,200.00
−0.68%Year over year
Reported trailing growth
- Revenue
- +208.4%
- EBITDA
- —
- EBIT
- +49.6%
- EPS
- —
- Free cash flow
- +65.6%
- Operating cash flow
- +82.1%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +67.3%
- EBITDA
- -35.2%
- EBIT
- +9.2%
- Net income
- —
- EPS
- —
- Free cash flow
- +33.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026